Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions
Sponsor: The University of Texas Health Science Center, Houston
Summary
This is a 7-year prospective single-center registry study to assess the safety and efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the treatment of pancreatic lesions.
Official title: Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions: A Pancardinal-4 Prospective Registry
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2026-04-07
Completion Date
2033-04-01
Last Updated
2026-07-30
Healthy Volunteers
Not specified
Conditions
Interventions
Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA)
EUS-guided Radiofrequency Ablation (RFA) consists of the application of alternating current with a frequency of 350-500 kHz (coincidentally the frequency range of radio broadcasts as well) to the target tissue via a special electrode located at the tip of the endoscope.
Locations (1)
The University of Texas Health Science Center at Houston
Houston, Texas, United States